Physician profile
Jared J Lund
NPI 1144424763
$14,299.18
in general payments reported to CMS, 2019-2025
36 companies · $2,147 in 2025
The $2,147 reported for 2025 was more than what 89% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $932 · 2021: $2,729 · 2022: $2,946 · 2023: $2,286 · 2024: $2,686 · 2025: $2,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,028 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,028.19 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,520.68 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,498.25 | 2019-2025 | |
| Janssen Biotech, INC. | $1,474.23 | 2019-2025 | Tremfya |
| Incyte Corporation | $938.71 | 2021-2025 | Opzelura, Iclusig |
| Sun Pharmaceutical Industries INC. | $742.79 | 2019-2025 | Ilumya, Blu-U, Winlevi |
| Regeneron Healthcare Solutions, INC. | $649.39 | 2020-2025 | Dupixent |
| Lilly USA, LLC | $596.99 | 2019-2025 | Olumiant, Taltz, Ebglyss |
| Amgen INC. | $535.25 | 2020-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $437.23 | 2019-2025 | Aklief, Epsolay, Twyneo |
| Leo Pharma INC. | $417.82 | 2022-2025 | Adbry |
| Genzyme Corporation | $355.48 | 2019-2025 | |
| Ucb, INC. | $355.25 | 2019-2025 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $227.72 | 2019-2024 | Jublia, Arazlo, Cabtreo |
| Pfizer INC. | $209.31 | 2021-2023 | |
| Surgenex LLC | $181.36 | 2025 | Ardeograft, Surmatrix, Pellograft |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $158.85 | 2022-2024 | Sotyktu |
| Vyne Pharmaceuticals INC. | $137.90 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.80 | 2023-2025 | Spevigo |
| Organogenesis INC. | $98.59 | 2021-2025 | Novachor, Cygnus Dual |
| Arcutis Biotherapeutics, INC. | $95.77 | 2023-2025 | Zoryve |
| Dermavant Sciences, INC. | $92.38 | 2023-2024 | Vtama |
| Botanix Sb INC | $58.38 | 2025 | Sofdra |
| Almirall LLC | $55.40 | 2020-2021 | |
| Epi Health, LLC | $54.92 | 2021-2022 | |
| Verrica Pharmaceuticals INC. | $43.93 | 2024 | Ycanth |
| Polynovo North America LLC | $39.33 | 2022 | |
| Biofrontera INC. | $32.78 | 2020-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Helsinn Therapeutics (U.S.), INC. | $28.24 | 2024 | Valchlor |
| Mallinckrodt Hospital Products INC. | $24.28 | 2025 | Acthar |
| Genentech USA, INC. | $23.84 | 2022 | |
| Mayne Pharma Commercial LLC | $23.31 | 2019 | |
| Dusa Pharmaceuticals, INC. | $22.91 | 2019 | |
| Fresenius Kabi USA, LLC | $16.38 | 2024 | Idacio |
| Strata Skin Sciences, INC. | $16.23 | 2024 | Xtrac |
| Prugen, INC. Pharmaceuticals | $14.41 | 2019 | |
| Organon LLC | $4.09 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Lund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.